 | Articles: Drug/Product Alerts |
Risk of serious skin disorders among users of oral antifungals: a population-based study
BMC Dermatology, 01/20/03
Alosetron (Lotronex) is back: Should I use it to treat my patients with irritable bowel syndrome?
Cleveland Clinic Journal of Medicine, 01/10/03
Reporting of adverse drug reactions in randomised controlled trials: a systematic survey
BMC Clinical Pharmacology, 01/09/03
 | | Sponsor |
FDA Approves New Labels for Estrogen and Estrogen with Progestin Therapies for Postmenopausal Women Following Review of Womens Health Initiative Data
FDA Press Releases , 01/09/03
Dead Bugs Don't Mutate: Susceptibility Issues in the Emergence of Bacterial Resistance
Emerging Infectious Diseases, 12/26/02
Molecular Surveillance System for Global Patterns of Drug Resistance in Imported Malaria
Emerging Infectious Diseases, 12/26/02
Adverse drug reactions and off-label drug use in paediatric outpatients
British Journal of Clinical Pharmacology, 12/20/02
Heparin-induced thrombocytopenia and thrombosis. Thrombosis as an early cardinal symptom of heparin allergy
Der Chirurg, 12/19/02
Adriamycin-induced Cardiomyocyte and Endothelial Cell Apoptosis: In Vitro and In Vivo Studies
Journal of Molecular and Cellular Cardiology, 12/13/02
Exophiala Infection from Contaminated Injectable Steroids Prepared by a Compounding Pharmacy - United States, July-November 2002
Morbidity and Mortality Weekly Report, 12/13/02
|
 Receive daily email updates on Drug/Product Alerts
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
105 Available Pages
 |
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
|
